Werewolf Therapeutics, Inc
Werewolf Therapeutics, Inc., based in Watertown, MA, is an innovative biotechnology company focused on developing transformative cancer therapies through advanced immunotherapy techniques. Their proprietary PREDATOR protein engineering technology allows for the creation of conditionally activated proinflammatory immune modulators, designed to enhance the body's immune response to cancer while minimizing off-target effects on healthy tissues.
The company's novel INDUKINE molecules are administered in an inactive form and selectively activated within the tumor microenvironment, unleashing a potent immune response against cancer cells. Led by a team of experienced physician-scientists and industry veterans, Werewolf Therapeutics aims to redefine the cancer treatment landscape with potentially best-in-class therapies that improve the lives of patients living with cancer.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
